In our subgroup analysis, serum YKL-40 was positively associated with poor outcome and all-cause mortality in patients without SAP, while the positive association in patients with SAP did not reach statistical significance.
← all excerpts
Prognostic performance of serum YKL-40 for one-year clinical outcomes in acute ischemic stroke.
2
—
—
The sentences
These may be significant explanations for poor clinical prognosis.